AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Malec, M Bjorklund, E Soderhall, S Mazur, J Sjogren, AM Pisa, P Bjorkholm, M Porwit-MacDonald, A
Citation: M. Malec et al., Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL, LEUKEMIA, 15(5), 2001, pp. 716-727

Authors: Prados, MD Wara, WM Sneed, PK McDermott, M Chang, SM Rabbitt, J Page, M Malec, M Davis, RL Gutin, PH Lamborn, K Wilson, CB Phillips, TL Larson, DA
Citation: Md. Prados et al., Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme, INT J RAD O, 49(1), 2001, pp. 71-77

Authors: Fuchsjager-Mayrl, G Polska, E Malec, M Schmetterer, L
Citation: G. Fuchsjager-mayrl et al., Unilateral light-dark transitions affect choroidal blood flow in both eyes, VISION RES, 41(22), 2001, pp. 2919-2924

Authors: Levin, VA Lamborn, K Wara, W Davis, R Edwards, M Rabbitt, J Malec, M Prados, MD
Citation: Va. Levin et al., Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine,and vincristine chemotherapy with radiotherapy for treating malignant glioma in children, NEURO-ONCOL, 2(1), 2000, pp. 22-28

Authors: Hellstrom, AC Blegen, H Malec, M Silfversward, C Lystad, S Borresen-Dale, A Auer, G
Citation: Ac. Hellstrom et al., Recurrent fallopian tube carcinoma: TP53 mutation and clinical course, INT J GYN P, 19(2), 2000, pp. 145-151

Authors: Malec, M
Citation: M. Malec, Before you sign on the dotted line (Get as detailed a job description as you can before signing a contract), DANCE MAG, 74(5), 2000, pp. 69-69

Authors: van Dongen, JJM Macintyre, EA Gabert, JA Delabesse, E Rossi, V Saglio, G Gottardi, E Rambaldi, A Dotti, G Griesinger, F Parreira, A Gameiro, P Diaz, MG Malec, M Langerak, AW San Miguel, JF Biondi, A
Citation: Jjm. Van Dongen et al., Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease - Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia, LEUKEMIA, 13(12), 1999, pp. 1901-1928
Risultati: 1-7 |